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1. Introduction 
The security system of the body against pathogenic invaders includes leukocytes that 
efficiently scan the organism. Leukocytes within the vasculature utilize the comprehensive 
circulatory system to examine the blood vessels of the entire body for signs of e.g. bacteria 
displayed on vascular endothelial cells. Upon infection, a successful immune response is 
dependent on prompt recruitment of leukocytes from the bloodstream to the afflicted site 
where they exert their effector functions. A critical aspect of leukocyte recruitment out of 
vasculature is the chemotactic gradient that guides leukocytes over the blood vessel wall, and 
further through the extracellular matrix towards the affected site. Leukocyte recruitment is a 
strictly regulated cascade of events involving different molecular mechanisms. To rapidly and 
efficiently reach their target, specific interactions between circulating leukocytes and vascular 
endothelium orchestrates leukocyte activation and guides them already within blood vessels 
to optimal transmigration sites at endothelial loci close to the source of inflammation. 
Despite the obvious need for effective leukocyte recruitment to eradicate bacteria and to 
maintain tissue homeostasis, amplified and dysregulated recruitment of leukocytes is a key 
factor in diverse disorders including autoimmune diseases and sepsis. For many of these 
conditions, therapeutic options are limited and unspecific. Understanding the triggering 
signals, involved molecules and underlying mechanisms by which the body enhances, 
controls and limits immune responses is therefore critical for the development of novel 
therapeutic interventions. 
In this chapter we summarize leukocyte recruitment during inflammation, highlighting a 
recent finding, namely intravascular leukocyte chemotaxis. 
2. Leukocyte recruitment and chemotaxis  
Over the last years, research groups have been dedicating their efforts to delineate the 
cellular and molecular mechanisms behind leukocyte recruitment using a wide range of in 
vivo imaging techniques (e.g. fluorescence intravital microscopy, spinning disk confocal, as 
well as two-photon confocal microscopy). These techniques, together with genetically 
altered mice (transgenic or knockout) combined with fluorescently labeled proteins and 
antibodies, allow detailed examination of leukocyte-endothelial cell interactions, adhesion 
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molecule expression and chemokine distribution. Thereby, an expanded and more detailed 
version of the leukocyte recruitment cascade was established. 
Leukocyte recruitment can be described as a sequential process having at least five distinct 
events, as depicted in Figure 1, induced by upregulation of endothelial adhesion molecules 
and molecular guidance signals (chemotactic stimuli). 
 
 
Fig. 1. The leukocyte recruitment cascade. The vessels is stained red by monoclonal 
antibodies to CD31 conjugated to Alexa Fluor 555, and cartoon neutrophils are added to the 
phtograph. The white boxes contain involved adhesion molecules, where the ones expressed 
by neutrophils are written in italics. Illustration adapted with permission from Phillipson M, 
Kubes P, Nature Medicine, 2011.  
2.1 Leukocyte tethering and rolling 
In order to leave the vasculature at the site of infection, leukocytes have to become marginated, 
leave the center of the blood stream, and decelerate to come in contact with the vascular 
endothelium. However, due to the force of blood flow in postcapillary venules (shear rate 150 
to 1600 s-1, depending on flow rate and vessel diameter) collisional contact duration between 
leukocytes and unstimulated endothelium is brief (i.e. <25 ms) (Simon S. I., Goldsmith H. L., 
2002). Specific interaction mechanisms between leukocytes and activated endothelium under 
shear flow are therefore required for leukocyte recruitment to inflammatory foci. 
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In fact, during inflammation, locally released stimuli (e.g. bacterial peptides, complement 
fragments, chemokines, histamine, and damage-associated molecular patterns) activate 
endothelial cells in the nearby venules to upregulate adhesion molecules on the plasma 
membrane which will aid leukocyte tethering, slow rolling and adhesion to the 
endothelium, leading ultimately to leukocyte transmigration into the tissue. 
Selectins are a family of long adhesive molecules, extending from the plasma membrane, 
which facilitate attachment of circulating leukocytes to the endothelium (Patel K. D. et al., 
1995; Kansas G.S., 1996). Increased expression of P- and E-selectin (CD62P and CD62E, 
respectively) on activated venular endothelium induces leukocyte tethering (Kunkel E. J., 
Ley K., 1996; Petri B. et al., 2008). While P-selectin is stored in Weibel-Palade bodies within 
the endothelial cells, E-selectin requires de novo synthesis. Once tethered, leukocytes can 
rapidly release and reengage selectin ligand bonds, resulting in a slow rotational movement 
along the vessel wall termed rolling (Norman M. U., Kubes P., 2005; Kelly M. et al., 2007; Ley 
K. et al., 2007). Rolling dynamics is optimized by force-regulated transitions from catch 
bonds to slip bonds1, which explains the requirement for a shear threshold to support 
rolling (McEver R. P., Zhu C., 2010). L-selectin (CD62L), constitutively expressed on 
leukocytes, participates redundantly with P- and E-selecting, and supports both capture and 
rolling of leukocytes in blood vessels (Kunkel E. J., Ley K., 1996; Petri B. et al., 2008).  
Each of the three selectins binds with different affinity to sialylated and fucosylated 
oligosaccharides including sialyl LewisX (sLeX) moieties, which are present on multiple 
glycolipids and glycoproteins on leukocytes and endothelium (McEver R. P., 2001; Simon S. 
I., Green C. E., 2005; Kelly M. et al., 2007). The best characterized selectin ligand is PSGL-1 
(P-selectin glycoprotein ligand-1), a heavily sialylated mucin present on leukocytes and 
endothelial cells, which can serve as a ligand to P-, E- and L-selectins although it binds P-
selectin with the highest affinity (Kansas G. S., 1996). Besides PSGL-1, other ligands have 
been identified for E-selectin, e.g. sialophorin (leukosialin, CD43), hematopoietic cell E-
selectin ligand (HCELL, CD44), and E-selectin ligand-1 (ESL1) (Kelly M. et al., 2007; Ley K. et 
al., 2007). L-selectin can also bind other ligands e.g. glycosylation-dependent cell adhesion 
molecule-1 (GlyCAM-1), mucosal addresin cell adhesion molecule-1 (MAdCAM-1), 
podocalyxin (CD34), heparan sulfate (HS) and sulphated glycoprotein-200 (Sgp200) (Wang 
L. et al., 2005). 
Rolling along the endothelium provides leukocytes a great opportunity to interact with and 
be further activated by chemokines or other inflammatory mediators presented on the 
luminal endothelium. 
2.2 Intravascular chemokine presentation to rolling leukocytes 
To initiate activation and recruitment of circulating leukocytes to tissue, tissue-derived 
chemokines need to be presented to rolling leukocytes at the apical endothelium. Within 
blood vessels, immobilization of chemokines on the endothelium is essential to avoid that 
they are washed away from the site of inflammation by the blood flow. 
                                                 
1 Catch bond: a bond that prolongs its lifetime in response to tensile force; Slip bond: a bond that shortens 
its lifetime in response to tensile force (McEver R. P., Zhu C., 2010). 
www.intechopen.com
 
Hematology – Science and Practice 
 
232 
Heparan sulfate proteoglycans (HSPGs) are proteins bearing covalently attached complex 
polysaccharide chains that are negatively charged (heparan sulfate, HS), and are found on 
cell surfaces of most cell types as well as in the extracellular matrix (Bernfield M. et al., 1999, 
Parish C., 2005). Chemokines and a variety of positively charged proteins bind to HS 
through specific and/or electrostatic interactions (Lindhal U., Kjellén L., 1991; Lindhal U., 
2007). Indeed, interstitially released chemokines were shown to cross the endothelium and 
to be presented by luminal HSPGs to leukocytes both in vitro (Ihrcke N. S. et al., 1993; Parish 
C., 2005; Wang L. et al., 2005; Lindhal U., 2007) and in vivo (Massena S. et al., 2010). Binding 
of chemokines to endothelial HSPG may promote molecular encounters between rolling 
leukocytes and chemokines, and thereby further inducing leukocyte activation. Moreover, 
endothelial HS acts as a ligand for L-selectin aiding neutrophil slow rolling (Wang L. et al., 
2005), which increase the propensity for leukocyte-chemokine encounters. 
How chemokines originating from the afflicted site or released by tissue leukocytes reach 
the luminal side of the endothelium in order to be presented by HS to leukocytes is not 
completely established. However, electron microscopy studies suggested that chemokines 
bound to HS are transported through the endothelium by transcytosis (Middleton J. et al., 
1997) as endothelium exposed to interleukin-8 (IL-8, CXCL8) contained IL-8 within 
intracellular caveola, while no chemokines were found at endothelial cell junctions. 
Nevertheless, under the experimental conditions of this study, it is impossible to tell if the 
intracellular chemokines are being transported through endothelium towards the apical 
membrane or if they are on their way to lyzosomes for degradation. In addition, soluble 
chemokines passing through junctions cannot be detected using electron microscopy, as 
they would be lost during tissue preparation prior to examination. 
Edema formation is one of the cardinal signs of inflammation, and is caused by increased 
vascular permeability and consequent plasma leakage. The primary cause of increased 
vascular permeability is leakage of plasma through paracellular gaps (Curry F. E., Adamson 
R. H., 2010; Lindbom L., Kenne E., 2011), which is regulated by the interplay of adhesive 
forces between adjacent endothelial cells and counter adhesive forces generated by 
endothelial actomyosin contraction (Mehta D., Malik A. B., 2006). The physiological 
importance of this event for leukocyte recruitment is debated. It is well documented that 
increased vascular permeability in presence of inflammatory mediators is accompanied by 
increased leukocyte adhesion and diapedesis (Curry F.E., Adamson R. H., 1999; Michel C. 
C., Curry F. E., 1999). Nevertheless, temporal and spatial uncoupling between these two 
events has also been described. During inflammation, vascular permeability can increase at 
a faster rate than leukocyte transmigration (Kim M. H. et al., 2009), suggesting that increased 
vascular permeability precedes leukocyte recruitment. Further, in aseptic wounds, vascular 
permeability and leukocyte extravasation were shown to be uncoupled (Curry F.E., 
Adamson R. H., 1999; Kim M. H. et al., 2009). It is generally believed that increased 
permeability supports chemokine influx into the vessels and one hypothesis is that the 
increase in vascular permeability during inflammation grants the paracellular transport of 
chemokines for rapid presentation to intravascular leukocytes, guiding them out to the 
afflicted area in the tissue. A recent study using intravital spinning-disk confocal 
microscopy in anesthetized mice revealed that chemokines added extravascularly became 
accumulated intra-luminally at endothelial cell junctions (Massena S. et al., 2010). High 
junctional sequestration of chemokines suggests that chemokines are transported either 
paracellularly into blood vessels or longitudinally on the apical endothelial cell membrane 
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towards junctions after being transcytosed. Further, this observation might simply reflect 
high concentrations of HS in junctional regions. However, these findings suggest that 
increased vascular permeability during inflammation does not necessary account for 
amplified leukocyte extravasation per se, but instead might promote cytokine/chemokine 
transport and thereby induce leukocyte recruitment. 
Endothelial cells display extraordinary phenotypic and functional heterogeneity. 
Endothelial cell structural features such as shape, thickness, molecular characteristics of 
apical membrane and junctions, as well as the thickness of the luminal glycocalyx are some 
of the features, which vary across the vascular tree (Van Den Berg B. M. et al., 2003; Aird W. 
C., 2007). Heparan sulfate is known to display miscellaneous structural features in various 
tissues and on different cell types (Lindhal U., Li J. P., 2009), which accounts for binding of 
proteins in a selective fashion. Differences in proteoglycan composition (altered structure of 
HS epitopes or sequences, and/or expression pattern of different syndecans) might result in 
different chemokine binding properties, explaining the observed differences in leukocyte 
recruitment of different organs upon diverse inflammatory stimuli. 
2.3 Leukocyte activation and adhesion to the endothelium 
After being stimulated by chemokines sequestered on the endothelium, rolling leukocytes 
adhere to the endothelium by rapid formation of shear-resistant bindings mediated by 
specialized leukocyte integrins (Rose D. M. et al., 2007). Integrins are noncovalently 
associated heterodimeric cell surface adhesion molecules consisting of combinations of  
and -molecules. Leukocytes express at least 10 members of the integrin family belonging to 
the 1-, 2- and 7-subfamilies (Luo B. H. et al., 2007). Leukocyte adhesion molecules relevant 
for recruitment belong to the 1- and 2-integrin families (Ley K. et al., 2007), of which LFA-1 
(Lymphocyte function-associated antigen-1, ITGAL, CD11a/CD18, L2), Mac-1 
(Macrophage antigen-1, ITGAM, CD11b/CD18, M2) and VLA-4 (very late antigen-4, 
CD49d/CD29, 41) are the most studied. 
Members of the 1-subfamily (also called VLA integrins) contain the 1-subunit associated to 
one of at least six different  subunits (Hemler M. E., 1990). VLA-4 integrin is amply 
expressed on peripheral blood B-lymphocytes, T-lymphocytes and monocytes (Hemler M. 
E., 1990). Peripheral blood neutrophils are believed to generally be devoid of cell surface 1-
integrin structures (Hemler M. E., 1990), even though some reports claim that immature 
neutrophils expressing surface VLA-4 can also be found in circulation (Lund-Johansen F., 
Terstappen L. W., 1993; Pillay J. et al., 2010). 
Most circulating leukocytes express integrins in a low affinity state (Carman C. V., Springer 
T. A., 2003). Upon binding of chemokines to G-protein-coupled receptors (GPCRs) 
expressed on leukocytes, a complex intracellular signaling network is triggered within 
milliseconds (Shamri R. et al., 2005; Ley K. et al., 2007). This induces integrins to undergo an 
almost instantaneous change in avidity and ligand affinity (Von Andrian U. H. et. al., 1992; 
Shamri R. et al., 2005; Hyduk S. J., Cybulsky M. I., 2009). Thus, inside-out signaling after 
chemokine binding to GPCRs shifts the integrins from a resting to an active conformation 
(Simon S.I., Goldsmith H. L., 2002; Simon S. I., Green C. E., 2005), which is necessary for 
binding to its ligands expressed on activated endothelial cells (Ley K. et al., 2007). 
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Differential leukocyte expression levels of integrins and chemokine receptors as well as 
receptor affinity for chemokines might account for selective arrest and recruitment of 
leukocyte subtypes. Additionally, chemokine-triggered signaling networks can regulate 
distinct integrins in specific leukocyte subtypes, contributing for differential leukocyte 
recruitment. 
2.3.1 Neutrophil adhesion 
2-integrin dependent neutrophil adhesion is fundamental for effective bacterial clearance. 
In fact, the genetic disorder leukocyte adhesion deficiency I (LAD I) is characterized by a 
profound defect in leukocyte recruitment and therefore severe immunodeficiency, due to 
neutrophils failing to adhere to the activated endothelium since the surface levels of 2-
integrins are dramatically reduced or absent (Bunting M. et al., 2002). 
It was recently found that binding of the 2-integrin LFA-1 to intercellular adhesion 
molecule-1 (ICAM-1, CD54) expressed by endothelial cells, mediates neutrophil firm 
adhesion to the vascular endothelium under shear flow (Shamri R. et al., 2005; Phillipson M. 
et al., 2006; Ley K. et al., 2007; Petri B. et al., 2008). LFA-1 is also able to bind to other 
immunoglobulin superfamily members, ICAM-2 (CD102) and ICAM-3 (CD50), albeit with 
lower affinity relative to ICAM-1 (De Fougerolles A. R. et al., 1994), in addition to JAM-A 
(junction adhesion molecule-A). 
However, there is some evidence that neutrophils adhere via other adhesion molecules than 
LFA-1, or by non-adhesion processes such as physical trapping, described to occur in lung 
capillaries or liver sinusoids (Doerschuk C. M. et al., 1990; Wong J. et al., 1997; Norman M. 
U., Kubes P., 2005). Indeed, anti-CD18 treatment did not reduce leukocyte recruitment to the 
lung of rabbits (Doerschuk C. M. et al., 1990), or in the rat liver (Jaeschke H. et al., 1996). In 
the liver, neutrophils have been reported to adhere via CD44 interacting with sinusoidal 
hyaluronan (McDonald B. et al., 2008). Furthermore, under systemic inflammatory 
conditions, such as sepsis, neutrophils have been suggested to adhere to the endothelium 
via VLA-4 (Ibbotson G. C. et al., 2001). This integrin was also proposed to be involved in 
neutrophil adhesion in the lung microvasculature (Ibbotson G. C. et al., 2001). 
2.3.2 Monocyte adhesion 
In contrast to neutrophil adhesion, 2-integrins seem to play a moderate role in monocyte 
arrest, since monocytes both adhere and polarize after blockade of 2-integrins as well as 
after blockade of ICAM-1 or ICAM-2 in vitro (Schenkel A. R. et al., 2004). Instead, 1-
integrins seem to play a more substantial role in monocyte adhesion to the endothelium. In 
fact, recent mouse models showed that monocytes firmly adhered to endothelium by VLA-4 
binding to endothelial VCAM-1 (vascular cell adhesion molecule-1, CD106) (Luscinkas F. W. 
et al., 1994; Meerschaert J., Furie M. B., 1995; Lee T. D. et al., 2003; Ley K. et al., 2007; 
Soehnlein O. et al., 2009). 
2.3.3 Lymphocyte adhesion 
During lymphocyte recruitment to peripheral tissues, LFA-1 is the dominant integrin 
involved in firm adhesion (Dustin M., Springer T. A., 1989; Shamri R. et al., 2005) by binding 
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to its ligand ICAM-1 (Shamri R. et al., 2005). As described for neutrophils, LFA-1 prevails in 
a low affinity state on most circulating lymphocytes. Stimulation of lymphocyte-GPCRs 
rapidly shifts LFA-1 integrin to a high avidity state (Carman C. V., Springer T. A., 2003). 
This high avidity state of LFA-1 on T-lymphocytes is transient, peaking 5 to 10 minutes after 
receptor stimulation and returns to the low affinity state by 30 min to 2 hours (Dustin M., 
Springer T. A., 1989). 
T-lymphocytes are not only recruited to tissue, they also home to lymph nodes. In vitro 
studies of T-lymphocyte adhesion to the specialized lymph node endothelium (high 
endothelial venules, HEV), demonstrated that besides LFA-1, VLA-4 is involved in T-cell 
adhesion (Faveew C. et al., 2000). Adhesion was reduced by 40-50% upon treatment with 
inhibiting antibodies to either integrin. Interestingly, the effects of VLA-4 and LFA-1 
antibodies were additive, giving >90% inhibition of T-lymphocyte adhesion. 
2.4 Intravascular chemotactic gradients and leukocyte crawling 
Using time-lapse in vivo microscopy, adherent neutrophils and monocytes were recently 
observed to crawl significant distances within the vessels (Phillipson M. et al., 2006; Auffray 
C. et al., 2007; Phillipson M. et al., 2009). The crawling neutrophils were searching the 
endothelium for optimal sites for transmigration, since inhibition of crawling significantly 
delayed neutrophil transmigration (Phillipson M. et al., 2006; Sumagin R. et al., 2010). 
2.4.1 Neutrophil crawling 
Intravascular crawling of neutrophils is dependent on the leukocyte 2-integrin Mac-1 and 
its ligand ICAM-1 on endothelial cells (Phillipson M. et al., 2006; Sumagin R. et al., 2010). 
Compared to LFA-1, Mac-1 binds a wider spectrum of ligands, including complement 
fragment iC3b, fibrinogen, fibronectin, laminin, collagen, myeloperoxidase, elastase, JAM-B 
and –C to name just a few (Simon S. I., Green C. E., 2005; Kelly M. et al.,  2007; Luo B. H. et 
al., 2007) suggesting that this integrin might have other roles apart from intravascular 
crawling. 
Neutrophil crawling on the stimulated endothelium occurs in two distinct stages. In the 
initial phase directly following neutrophil adhesion, a mechanotactic signal provided by 
shear stress induces neutrophil crawling perpendicular to blood flow until an endothelial 
cell junction is encountered (Phillipson M. et al., 2009). This observation has also been made 
in vitro when adherent neutrophils crawled perpendicular to the direction of flow when 
shear was applied to the system (Phillipson M. et al., 2009). However, as soon as the 
crawling neutrophils meet the junction, the shear stress signal is ignored and neutrophils 
instead begin to follow the junction. Considering that endothelial cells are elongated in the 
direction of flow, perpendicular crawling generates the greatest probability for a neutrophil 
to find an endothelial junction in the shortest period of time. 
More recently, the existence of an intravascular gradient of chemokines (macrophage 
inflammatory protein-2, CXCL2 [MIP-2]; keratinocyte-derived chemokine, CXCL1 [KC]) 
originating from the infection or released by tissue leukocytes on endothelial cells has been 
described (Massena S. et al., 2010). Indeed, this chemotactic gradient is sequestered on 
endothelial HS and provides directional cues to crawling neutrophils, which follow this 
gradient to optimal transmigration sites close to the origin of the infection (Massena S. et al., 
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2010). However, whether haptotactic gradients can be established by all chemokines 
remains unclear, since different chemokines have diverse affinity to HS (Lindhal U., Kjellén 
L., 1991; Lindhal U., 2007). 
Directional intravascular crawling along a chemotactic gradient expedites neutrophil 
recruitment, compared to when no chemokine gradient is formed due to homogenous 
extravascular chemokine concentrations (Massena S. et al., 2010). Disruption of the 
chemokine gradient is translated into random crawling and inefficient recruitment of 
neutrophils which ultimately leads to a decreased ability to clear infections, as seen in 
Staphylococcus aureus infected mice with truncated HS chains (overexpressing heparanase, 
Massena S. et al., 2010). 
2.4.2 Monocyte crawling 
Intravascular crawling monocytes have been reported in vivo (Auffray C. et al., 2007; 
Sumagin R. et al., 2010), and crawling on endothelium is critical to reach optimal 
transmigration sites, as demonstrated in vitro (Schenkel A. R. et al., 2004). 
Whereas the integrin Mac-1 alone is responsible for crawling of neutrophils, LFA-1 and 
Mac-1 integrins were in some studies reported to play a redundant role in monocyte 
crawling via binding to ICAM-1 and ICAM-2 (Schenkel A. R. et al., 2004; Sumagin R. et al., 
2010). Blockade of each of these molecules led to a pirouette behavior at the adhesion site 
(Schenkel A. R. et al., 2004). Nevertheless, monocytes were shown to be able to adhere and 
polarize. 
Recently, a distinct role for each of these integrins on monocyte crawling under different 
endothelial activation states has been described. Monocytes were shown to crawl long 
distances on resting endothelium in a patrolling behavior (i.e. monitoring healthy tissue) in a 
LFA-1-dependent manner (Auffray C. et al., 2007; Sumagin R. et al., 2010). However, upon 
inflammatory stimulation, monocyte crawling became Mac-1-dependent and assumed a 
neutrophil-like crawling pattern, i.e. similar crawling distance and confinement ratio 
(Sumagin R. et al., 2010). These results have been suggested to correspond to differences 
between two different monocyte populations rather than to a shift in integrin expression 
upon inflammatory stimulation. 
Two monocyte subsets distinguished by their expression levels of selectins, integrins and 
chemokine receptors have already been characterized in various mammals (Geissman F. et 
al., 2003; Gordon S., Taylor P. R., 2005). These phenotypic differences encompass distinct 
effector functions. A monocyte subset termed "resident" (CX3CR1hi CCR2- Ly6C- in mice; 
CD14lo CD16+ in humans) is involved in tissue remodeling and wound repair (Gordon S., 
Taylor P. R., 2005; Auffray C. et al., 2007; Soehnlein O. et al., 2009). In contrast, another 
monocyte subset denominated "inflammatory" (CX3CR1lo CCR2+ Ly6C+ in mice; CD14hi 
CD16- in humans) is specialized in pro-inflammatory activities such as bacterial 
phagocytosis, secretion of inflammation-promoting cytokines and reactive species as well as 
proteolytic activity (Gordon S., Taylor P. R., 2005; Auffray C. et al., 2007; Soehnlein O. et al., 
2009). Resident monocytes, express high amounts of LFA-1. In contrast, inflammatory 
monocytes do not express LFA-1, even though no differences were found for Mac-1 between 
the two monocyte subsets (Auffray C. et al., 2007). 
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It is possible that the two subsets of circulating monocytes might use different integrins and 
display different crawling patterns to achieve the different effector functions. 
2.4.3 Lymphocyte crawling 
In vitro, adherent T-lymphocytes have been reported to crawl over the luminal surface of the 
endothelium in a LFA-1-dependent manner (Shulman et al., 2009). LFA-1 is also responsible 
for T-lymphocyte adhesion, but the distribution of the membrane LFA-1 is altered 
correlating with changes in cell morphology as soon as the T-lymphocyte starts to migrate 
(Smith A. et al., 2005). LFA-1 turnover at numerous focal points ensures rapid crawling and 
resistance to detachment by shear forces (Shulman et al., 2009). Low expression levels of 
LFA-1 were detected at the leading edge of the cell and high expression level in the non-
attached uropod at the rear (Smith A. et al., 2005). Interestingly, LFA-1 in the leading edge 
was not in a high-affinity state, as detected by use of specific antibodies that recognize LFA-
1 in different conformational states (Smith A. et al., 2007). Instead LFA-1 in the leading edge 
was in an intermediate affinity conformation allowing crawling possibly by weaker 
interactions with ICAM-1. 
Published studies have identified intravascular natural killer T-lymphocytes (NKT cells) 
with possible sentinel functions for the detection of bacteria in the blood (Geissmann F. et al., 
2005; Lee T. D. et al., 2010; Thomas S. Y. et al., 2011). These cells are distinguished by their 
restricted repertoire of T-cell receptor (TCR) variants that recognize lipids and glycolipids 
presented by CD1d (Kawano T. et al., 1997; Brossay L. et al., 1998). NKT cells primarily 
reside and wander within the vasculature of the liver and spleen (Geissmann F. et al., 2005; 
Bendelac A. et al., 2007) but have also been suggested to accumulate in smaller amounts in 
the vascular compartment of the lung (Thomas S. Y. et al., 2011). The mechanisms 
underlying adhesion and crawling of NKT cells are still poorly understood. It has been 
reported that treatment of mice with blocking antibodies to LFA-1 and ICAM-1 induced 
rapid detachment of adherent NKT cells from sinusoidal endothelium (Thomas S. Y. et al., 
2011). In contrast, blocking VLA-4 or VCAM-1 had no effect. Integrin activation typically 
relies on inside–out signaling after chemokine binding to GPCRs (Ley K. et al., 2007). 
However, genetic ablation of CXCR6 (the major chemokine receptor expressed on NKT 
cells) or treatment with an inhibitor of GPCRs, did not induce detachment of NKT cells from 
liver microvasculature (Geissmann F. et al., 2005; Lee T. D. et al., 2010). Furthermore, 
previous studies on NKT cells transferred into CD1d-deficient mice suggested that TCR 
activation was not a prerequisite for NKT cells sinusoidal adhesion (McNab F. W. et al., 
2005; Wei D. G. et al., 2005). Crawling was also unimpeded in mice treated with anti-CD1d 
antibody (Lee T. D. et al., 2010). Interestingly, upon infection with the blood-borne  
pathogen Borrelia burgdorferi (a spirochete injected intravenously through tick bite), NKT 
cells were reported to slow their crawling and to accumulate in clusters on Kupffer cells in a 
GPCRs-dependent way (CXCR3, and CD1d) (Lee T. D. et al., 2010). Kupffer cells are 
specialized ramified macrophages, which line the walls of liver sinusoids and prevent the 
dissemination of pathogens via the blood by capturing and engulfing them. Kupffer cells 
can then present glycolipid antigens via CD1d (Lee T. D. et al., 2010). In the absence of 
Kupffer or NKT cells, dissemination of Borrelia burgdorferi occurred, suggesting a role for 
NKT cells in vascular surveillance for blood-borne pathogens captured by Kupffer cells (Lee 
T. D. et al., 2010).  
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2.5 Diapedesis: Trans- and paracellular routes 
Leukocyte diapedesis out of vasculature into affected tissue can occur both between 
neighboring endothelial cells (paracellularly through junctions) and directly through the 
endothelium (transcellularly) (Feng D. et al., 1998; Shaw S. K. et al., 2001; Carman C. V., 
Springer T. A., 2004; Engelhardt B., Wolburg H., 2004; Yang L. et al., 2005; Phillipson M. et 
al., 2006). The route employed most likely depends on inflammatory stimuli, as well as the 
type of leukocyte and vascular bed. 
Diapedesis has been reported to be mediated by numerous endothelial adhesion molecules 
expressed in high density at endothelial junctions, such as platelet-endothelial cell adhesion 
molecule 1 (PECAM-1, CD31), CD99, vascular endothelial-cadherins (VE-cadherins), 
endothelial cell-selective adhesion molecule (ESAM), ICAM-1 and -2 and JAMs (Luscinskas 
F. W. et al., 2002; Engelhardt B., Wolburg H., 2004; Yang L. et al., 2005; Ley K. et al., 2007; Lou 
O. et al., 2007; Petri B. et al., 2008; Woodfin A. et al., 2011). Other molecules involved in 
leukocyte transmigration are integrins expressed on leukocytes (e.g. LFA-1, Mac-1, VLA-4) 
(Ley K. et al., 2007; Petri B. et al., 2008; Woodfin A. et al., 2011). The specific molecules 
involved in either of the transmigration pathways remains to be identified. 
The different molecules appear to mediate leukocyte transmigration in either a stimulus-
specific or leukocyte-specific manner. For example PECAM-1, ICAM-2 and JAM-A mediate 
leukocyte transmigration in response to interleukin-1β (IL-1β) but not to tumor necrosis 
factor-alpha (TNF-) (Wang S. et al., 2006; Ley K. et al., 2007). Direct activation of leukocytes 
by TNF-, fMLP (N-formyl-methionyl-leucyl-phenylalanine) or leukotriene-B4 (LTB4) 
appears to bypass the need for these molecules. Studies of activated mouse cremaster 
muscle and intravital microscopy in mice knocked down for ESAM gene (Ley K. et al., 2007) 
have shown that ESAM does not show a stimulus-specific role but appears to mediate 
neutrophil rather than T-lymphocyte transmigration. 
Neutrophils have been found to transmigrate predominantly through the paracellular route, 
i.e. between adjacent endothelial cells (Phillipson M. et al., 2006; Woodfin A. et al., 2011). 
Paracellular transmigration was found to be dependent on the ability for leukocytes to crawl 
to optimal transmigration sites at the endothelial cell junctions. In Mac-1 deficient mice, due 
to inhibition of intravascular crawling, transcellular transmigration predominated 
(Phillipson M. et al., 2006). 
Using in vivo spinning disk or multi-photon confocal microscopy, profound anatomical 
changes of the endothelium that facilitated leukocyte extravasation without compromising 
vascular barrier integrity were observed (Phillipson M. et al., 2008; Petri B. et al., 2011). 
Docking cup-like structures were formed by endothelial cells (endothelial projections) at the 
base of the transmigrating neutrophil, which has also been described for T-lymphocytes in 
vitro (Carman C. V., Springer T. A., 2004). The endothelial projections extended towards the 
top of the neutrophil and eventually formed a dome that surrounded the entire neutrophil, 
prior to basolateral opening and neutrophil migration further into tissue. If the dome 
formations were prevented, neutrophil transmigration was delayed (Petri B. et al., 2011), 
further implicating an active role of endothelium during leukocyte diapedesis, while 
maintaining the barrier function and vascular permeability. 
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2.5.1 Migration through the subendothelial basement membrane and pericyte sheet 
To overcome the barrier of the blood vessel and finally reach the inflamed tissue, leukocytes 
also have to transmigrate across the subendothelial basement membrane (BM) surrounding 
the venular endothelium. This has been shown to occur in areas low in collagen IV, laminin-
10 and nidogen-2 (Wang S. et al., 2006). These areas were seen to be closely associated to 
gaps between pericytes (Wang S. et al., 2006). Interestingly, leukocytes have been observed 
to initiate transmigration through endothelium at sites superimposing these specific areas. 
How intravascular crawling leukocytes can detect these areas from the luminal side of the 
endothelium remains unknown.  
2.6 Extravascular crawling  
Following leukocyte diapedesis across the vessel wall, further movement in tissue is 
required in order for the leukocytes to reach the affected site to exert their effector functions. 
As within the vasculature, leukocyte movement in the tissue is guided by chemotactic 
gradients leading to the source (Foxman E. F. et al., 1997; Lindbom L., Werr J., 2002). Upon 
binding to GPCRs on leukocytes, chemoattractants trigger downstream signaling, which 
translates to cytoskeletal reorganization, polarization and directional locomotion (Friedl P. et 
al., 2001). Migrating leukocytes thereby adopt a polarized morphology consisting of a 
leading edge and a tail-like uropod (Friedl P. et al., 2001). 
In order to initiate movement, leukocytes have to establish adhesive contacts with the tissue 
stroma via interactions between the extracellular integrin domains and components of the 
extracellular matrix (ECM) (Friedl P. et al., 2001; Lindbom L., Werr J., 2002). Stimulation by 
encountered chemoattractants activates surface integrins and recruits additional integrins 
from cytoplasmic stores (Diamond M. S., Springer T. A., 1994; Friedl P. et al., 2001). Binding 
to ECM macromolecules triggers integrin-mediated signals, which regulate further integrin 
apposition, actin assembly, cell polarity, and migration (Friedl P. et al., 2001). 
Accumulating evidence suggests that leukocyte chemotaxis in the ECM is mostly associated 
with 1-integrins while a limited role for 2-integrins is described (Sixt M. et al., 2001). 
Members of the 1-family shown to be involved in leukocyte locomotion (Gao J. X., Issekutz 
A. C., 1997; Werr J. et al., 1998; Sixt M. et al., 2001) show high affinity interactions with 
proteins of the ECM, including fibronectin, vibronectin, collagen and laminin (Hemler M. E., 
1990). Circulating neutrophils are not believed to constitutively express 1-integrins. 
However, it has been suggested that upregulation of 2-integrins by chemotactic stimuli 
induced an outside-in signaling leading to mobilization of 1-integrins to the neutrophil 
surface, in order to prepare recruited neutrophils for subsequent interactions with ECM 
(Lindbom L., Werr J., 2002). There are also studies demonstrating upregulation of neutrophil 
surface expression of 1-integrins in association with emigration from the vasculature 
(Kubes P. et al., 1995; Werr J. et al., 1998). 
Another adhesion molecule involved in extravascular crawling is L-selectin. Indeed, studies 
using L-selectin-deficient mice revealed no role of L-selectin on leukocyte rolling or 
adhesion, but transmigration was significantly impaired (Hickey M. J. et al., 2000). 
Furthermore, leukocytes in L-selectin-deficient mice were unable to respond to directional 
cues (platelet activating factor [PAF]; KC) in the interstitium (Hickey M. J. et al., 2000). These 
findings provided strong evidence of an important L-selectin function in leukocyte 
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emigration and extravascular locomotion. Intriguingly, L-selectin expression on emigrated 
leukocytes is dramatically reduced in comparison to levels on circulating leukocytes (Hickey 
M. J. et al., 2000). Shedding of L-selectin upon transmigration has been reported both in vitro 
(Smith C. W. et al., 1991; Allport J. R. et al., 1997) and in vivo (Jutila M. A. et al., 1989). These 
results raise the possibility that L-selectin early in the recruitment cascade triggers 
downstream signals that modulate consecutive transmigration and migration in the 
interstitium (Hickey M. J. et al., 2000). 
Further, integrins bind different components of the tissue stroma and with diverse affinities 
(Lindbom L., Werr J., 2002). Leukocyte chemotaxis in the tissue is therefore influenced not 
only by the stimuli encountered but also by the matrix proteins in the tissue. 
2.6.1 Prioritazing chemotactic cues 
During bacterial infections, the chemotaxing leukocytes are exposed to a cacophony of 
different chemotactic gradients of diverse origins. Chemoattractants originate from the 
bacteria themselves (e.g. fMLP; lipopolysaccharide [LPS]) or complement fragments bound 
to bacteria (e.g. complement fragment C5a), but also from nearby activated leukocytes and 
endothelial cells (e.g. LTB4; IL-8) (Foxman E. F. et al., 1997; Heit B. et al., 2008; Muller W. A., 
2011). A microenvironment where numerous chemoattractants are encountered requires 
tightly regulated intracellular mechanisms for leukocytes to readily prioritize between the 
cues, in order for them to effectively reach the target. Thus, to fulfill their missions, 
leukocytes need to find the bacteria without being distracted by opposing gradients. A 
hierarchical relationship between chemotactic factors has developed, and “end-target” 
chemotactic factors like bacterial products versus the “intermediate” chemokines released by 
activated endothelium or tissue leukocytes have been shown to activate separate signaling 
pathways in neutrophils (p38-mitogen-activated protein kinase [p38MAPK] and 
phosphoinositide 3-kinase [PI3K], respectively [Campbell J. J. et al., 1997; Heit B. et al., 2002]). 
In this way, neutrophils are able to sort signals in the noisy environment of inflammation, 
and respond to chemotactic cues in a hierarchical manner, preferring “end-target” 
chemoattractant factors like fMLP and C5a over “intermediate” chemokines like IL-8 
(Foxman E. F. et al., 1997). This has been suggested to occur through the p38MAPK pathway 
inhibiting PI3K through relocalization of phosphatase and tensin homologue (PTEN) on the 
basolateral cell membrane of the polarized moving cell (Heit B. et al., 2008). However, 
additional parallel scenarios of how chemotacting leukocytes are directed to their goal have 
been described (PLA2, cGMP and DOCK2/phosphatic acid). Despite the mentioned 
advances in understanding how leukocytes find their way in tissue, many issues remain to 
be deciphered considering the very complex nature of the extravascular environment during 
infection. Leukocytes will not only encounter bacterial chemoattractants and chemokines, 
but also cytokines, lipids and complement fragments. Cytokines (IL-1β, TNF-) are released 
simultaneously during infection and induce chemokine production. Chemokines and 
cytokines have been shown to act in concert to direct leukocyte delivery and activation, and 
chemokines of different families have been demonstrated in vitro to synergistically enhance 
influx of both neutrophils and monocytes (Gouwy M. et al., 2008; Kuscher K. et al., 2009). 
Further, interplay between lipid chemoattractant LTB4, the cytokine IL-1β and the 
chemokine ligands to first CCR1 and later CXCR2 was shown in a model of arthritogenesis 
(Chou R. C. et al., 2010). This vividly demonstrates that leukocyte recruitment in vivo, in 
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contrast to during in vitro settings hardly is the result of release of a single chemokine, and 
that synergistic as well as opposing effects of involved signaling molecules are to be 
expected to enhance as well as steer the inflammatory response. This interplay needs to be 
further clarified and the importance of these observations has to be confirmed in vivo, to 
determine therapeutic targets during different inflammatory conditions. 
3. Additional stimuli for leukocyte recruitment 
Inflammation is closely linked to hypoxia, and numerous leukocytes are detected at sites of 
tissue ischemia (Eltzschig H. K., Carmeliet P., 2011). Severe hypoxia causes both apoptosis 
and necrosis of somatic cells, which results in release of various damage-associated danger 
signals, like DAMPs (danger associated molecular pattern molecules). DAMPs include 
molecules originating from the cytosol or the nucleus, such as adenosine triphosphate 
(ATP), formylated peptides from mitochondria, heat shock proteins, chromatin and 
galectins, that often undergo denaturation when leaving the intracellular milieu, where after 
they become pro-inflammatory (Kono H., Rock K. L., 2008). Even though most of them are 
not considered directly chemotactic, they induce leukocyte recruitment by activating tissue 
macrophages and nearby endothelial cells to secrete pro-inflammatory cytokines (e.g. IL-1) 
and chemokines (e.g. IL-8), in addition to upregulating expression of adhesion molecules on 
endothelial cells (Muller W. A., 2011). However, fomylated peptides originating from 
mitochondria were recently found to recruit neutrophils via activation of the fMLP receptor 
formyl-peptide receptor-1 (McDonald B. et al., 2010; Zhang Q. et al., 2010).  
During hypoxia and cell injury, recruited neutrophils are believed to contribute to wound 
healing processes by clearing the area of debris through phagocytosis. In addition to 
phagocytosis, leukocytes have recently been acknowledged for their role in angiogenesis 
and tissue remodeling both during health and disease. Neutrophils produce and store 
within their granules pro-angiogenic molecules such as VEGF-A (vascular endothelial 
growth factor-A, [Gaudry M. et al., 1997]) and MMP-9 (matrix metalloproteinase-9, [Ardi V. 
C. et al., 2007]). VEGF is a key player in blood vessel formation and has a direct chemotactic 
effect on endothelial cells, while the pro-angiogenic function of MMP-9 is attributed to its 
ability to digest extra cellular matrix (ECM), which pave way for new vessels as well as 
release and thereby activate ECM-bound VEGF and other growth factors. The neutrophils 
are in fact the only cells in the body that release MMP-9 free of its endogenous inhibitor 
TIMP (tissue inhibitor of metalloproteinase), and are therefore capable of deliver highly 
active MMP-9 to sites of angiogenesis (Ardi V. C. et al., 2007). The pro-angiogenic capacity of 
neutrophils has been demonstrated in a corneal injury model, where the number of 
infiltrated neutrophils positively correlated to angiogenesis and VEGF levels (Gong Y., Koh 
D. R., 2010). Neutrophil depletion significantly impaired tissue healing in this model, as well 
as the release of VEGF. Further, neutrophils recruited to islets of Langerhans transplanted to 
striated muscle were recently shown to be crucial for revascularization to occur, as 
transplantation of islets to neutropenic mice resulted in complete inhibition of islets 
revascularization (Christoffersson G. et al., 2010). Neutrophils were shown to accumulate at 
sites for islet engraftment and were specifically localized at the newly formed vessels, as 
demonstrated in Figure 2. 
Monocytes have also been shown to have pro-angiogenic properties. For instance, tissue 
healing following myocardial infarction requires sequential mobilization of the two 
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Fig. 2. Isolated pancreatic islets (blue) transplanted to muscle causes Gr1+ cell (green) 
accumulation (courtesy of G. Christoffersson). Blood vessels are stained with anti-CD31 
(red). Scale bar equals 100 µm. 
described monocyte subsets which exhibit opposing phenotypes (Nahrendorf M. et al., 
2007). Recruited “inflammatory” monocytes exhibit proteolytic activity and inflammatory 
functions, whereas monocytes of the “resident” subtype contribute to angiogenesis and 
have attenuated inflammatory properties (Nahrendorf M. et al., 2007).  
In the field of tumor biology, it is known that the ability of tumors to create an 
immunomodulating microenvironment to escape cytotoxic immune cells and to allow for 
angiogenesis is central for tumor growth. Different factors have been shown to skew tumor-
associated leukocytes including neutrophils and macrophages from a pro-inflammatory, 
anti-tumorigenic to a pro-tumorigenic, pro-angiogenic phenotype (Fridlender Z. G. et al., 
2009; Hanahan D., Weinberg R. A., 2011; Rolny C. et al., 2011). Indeed, the angiogenic switch 
in islet dysplasia and tumors in the RIP1-Tag2 transgenic mouse model of pancreatic cancer 
was mediated by tumor-infiltrated MMP-9 expressing neutrophils (Nozawa H. et al., 2006). 
The identity of these pro-angiogenic leukocytes is currently being investigated, and whether 
circulating subpopulations with pro-angiogenic and anti-inflammatory properties exist, or if 
they attain their phenotype giving the stimuli, are under debate. Myeloid-derived 
suppressor cells (MDSCs) are a heterogenic population that increases in numbers in the 
spleen and bone marrow of tumor bearing mice, and consists of monocyte and neutrophil 
subsets with potent ability of suppressing immune functions such as T-lymphocyte 
activation (Bronte V. et al., 2000). In mice, they express CD11b and Gr-1, where the GR-1hi 
CD11b+ corresponds to immature and mature neutrophil subpopulations while the Gr-1int 
CD11b+ to the monocyte subset (Peranzoni E. et al., 2010; Youn J. I., Gabrilovich D. I., 2010). 
How other surface markers differ from the classical pro-inflammatory neutrophils or 
monocytes are not completely established, but the roles of neutrophils during restitution 
and angiogenesis described above might indeed involve the neutrophil subset of MDSC. 
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Further characterization of the identities of leukocytes involved in tissue restitution and 
angiogenesis, and even more importantly their functions during these situations, is of great 
relevance. 
4. Therapeutic interventions 
A variety of disorders are associated with leukocyte activation and infiltration. Asthma 
(Fanta C. H., 2009; Broide D. H. et al., 2011; Minnicozzi M. et al., 2011); emphysema 
(Martinez F. J. et al., 2011); atherosclerosis (Ross R., 1999; Hansson G., 2005); inflammatory 
bowel disease (Khor B. et al., 2011); rheumatoid arthritis (Olsen N. J., Stein C. M., 2004; 
O’Dell J. R., 2004; Scott D. L., Kingsley G. H., 2006); multiple sclerosis (Frohman E. M. et al., 
2006); sepsis (Hotchkiss R. S., Karl I. E., 2003); and allograft rejection after transplantation 
(Savasta M., Lentini S., 2011; Arias M. et al., 2011), are just some examples of this broad 
spectrum. Although many details remain to be delineated, the consensus is that the over-
exuberant, maladaptive and/or uncontrolled inflammation is in the pathogenesis of these 
conditions and leads to tissue injury. 
Over the past few years, pharmacotherapeutic advances have been made, with most 
therapeutic options focusing on means to prevent leukocyte activation and recruitment. 
Anti-adhesion therapies directed against different adhesion molecules have been evaluated. 
However, despite positive data from animal studies, many of the integrin antagonists have 
failed in clinical trials or are associated with severe side effects (Rutgeerts P. et al., 2009; 
Fontoura P., 2010; Del Zoppo G. J., 2010). 
A new approach for reducing leukocyte recruitment to tissue was recently described in mice 
(Maiguel D. et al., 2011). This study was based upon a nearly 20-year-old observation for 
eosinophils, which, in response to activating antibodies trapping VLA-4-integrin in a high-
avidity state, were able to adhere but not migrate (Kuijpers T. W. et al., 1993). Accordingly, 
the recent study screened for selective small-molecule Mac-1 agonists, named leukadherins. 
These agonists caused increased intravascular adhesion, but not transmigration of 
neutrophils, resulting in reduced leukocyte recruitment in experimental models of acute 
peritonitis and nephritis. Integrin clustering or outside-in signaling were not induced by 
binding of the agonist, which might account for the lack of detectable vascular injury, even 
though the effects on tissue blood flow by the increased number of intravascular adherent 
neutrophils remains to be studied. These observations are all very intriguing, even though 
further experimental evaluation of this course of action is required. 
5. Conclusion 
Leukocyte recruitment is a hallmark event in acute and chronic inflammation. Tightly 
regulated activation of circulating leukocytes and intravascular leukocyte guidance by the 
establishment of chemokine gradients within blood vessels is fundamental for leukocytes to 
efficiently transmigrate to the inflamed tissue, where they finally exert their effector 
functions. Specific interactions between transmigrating leukocytes and the activated 
vascular endothelium orchestrate profound anatomical changes of the endothelium which 
facilitate leukocyte extravasation while maintaining the barrier function and vascular 
permeability. Targeting intravascular leukocyte chemotaxis and the gating property of the 
endothelium would limit leukocyte transmigration and/ or vascular permeability during 
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detrimental inflammation. Understanding the underlying mechanisms behind these 
processes might therefore contribute for the development of novel therapeutic interventions. 
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